about
Inhibition of platelet adhesion and aggregation by a defined region (Gly-486-Lys-502) of high molecular weight kininogenThe junctional adhesion molecule 3 (JAM-3) on human platelets is a counterreceptor for the leukocyte integrin Mac-1The homophilic binding of junctional adhesion molecule-C mediates tumor cell-endothelial cell interactionsThe junctional adhesion molecule-C promotes neutrophil transendothelial migration in vitro and in vivo348 CASES OF SUSPECTED NEONATAL ALLOIMMUNE THROMBOCYTOPENIACharacterization of platelet-specific mRNA by real-time PCR after laser-assisted microdissection.Leukocyte trans-endothelial migration: JAMs add new pieces to the puzzle.A functional platelet fibrinogen receptor with a deletion in the cysteine-rich repeat region of the beta(3) integrin: the Oe(a) alloantigen in neonatal alloimmune thrombocytopenia.Platelet receptor and clotting factor polymorphisms as genetic risk factors for thromboembolic complications in heparin-induced thrombocytopenia.Bernard-Soulier syndrome due to the homozygous Asn-45Ser mutation in GPIX: an unexpected, frequent finding in Germany.Ceftriaxone causes drug-induced immune thrombocytopenia and hemolytic anemia: characterization of targets on platelets and red blood cells.Immunization against a low-frequency human platelet alloantigen in fetal alloimmune thrombocytopenia is not a single event: characterization by the combined use of reference DNA and novel allele-specific cell lines expressing recombinant antigens.Relevance of the HPA-15 (Gov) polymorphism on CD109 in alloimmune thrombocytopenic syndromes.Functional heterogeneity of alloantibodies against the human platelet antigen (HPA)-1a.A naturally occurring LeuVal mutation in beta3-integrin impairs the HPA-1a epitope: the third allele of HPA-1.A prospective study on the prevalence and risk factors for neonatal thrombocytopenia and platelet alloimmunization among 9332 unselected Brazilian newborns.Rapid detection of HPA-1 alloantibodies by platelet antigens immobilized onto microbeads.Heterogeneity of HPA-3 alloantibodies: consequences for the diagnosis of alloimmune thrombocytopenic syndromes.Blockade of maternal anti-HPA-1a-mediated platelet clearance by an HPA-1a epitope-specific F(ab') in an in vivo mouse model of alloimmune thrombocytopenia.Low-avidity HPA-1a alloantibodies in severe neonatal alloimmune thrombocytopenia are detectable with surface plasmon resonance technology.Alloantibodies against low-frequency human platelet antigens do not account for a significant proportion of cases of fetomaternal alloimmune thrombocytopenia: evidence from 1054 cases.The first case of alloantibody against human platelet antigen-15b in Japan: possible alloimmunization by a hydatidiform mole.Performance characteristics of two commercially available IgG-specific immunoassays in the assessment of heparin-induced thrombocytopenia (HIT).A new platelet alloantigen, Swi(a) , located on glycoprotein Ia identified in a family with fetal and neonatal alloimmune thrombocytopenia.Low-avidity anti-HPA-1a alloantibodies are capable of antigen-positive platelet destruction in the NOD/SCID mouse model of alloimmune thrombocytopenia.Evaluation of a new nanoparticle-based lateral-flow immunoassay for the exclusion of heparin-induced thrombocytopenia (HIT).Autoantibody-mediated complement activation on platelets is a common finding in patients with immune thrombocytopenic purpura (ITP).A point mutation in the EGF-4 domain of β(3) integrin is responsible for the formation of the Sec(a) platelet alloantigen and affects receptor functionThe implementation of surface plasmon resonance technique in monitoring pregnancies with expected fetal and neonatal alloimmune thrombocytopenia.Inhibition of HPA-1a alloantibody-mediated platelet destruction by a deglycosylated anti-HPA-1a monoclonal antibody in mice: toward targeted treatment of fetal-alloimmune thrombocytopenia.Studies on CD36 deficiency in South China: Two cases demonstrating the clinical impact of anti-CD36 antibodies.Glycosylation of autoantibodies: insights into the mechanisms of immune thrombocytopenia.The role of alloantibodies against human platelet antigen-15 in multiply platelet transfused patients.Noninvasive fetal genotyping of human platelet antigen-1a using targeted massively parallel sequencing.Alloantibody against new platelet alloantigen (Lap(a)) on glycoprotein IIb is responsible for a case of fetal and neonatal alloimmune thrombocytopenia.A bead-based assay in the work-up of suspected platelet alloimmunization.Immunisation against αIIbβ3 and αvβ3 in a type 1 variant of Glanzmann's thrombasthenia caused by a missense mutation Gly540Asp on β3.Rapid characterization of hybridomas producing monoclonal antibodies against platelet β3 integrin using ELIspot.Antiendothelial αvβ3 Antibodies Are a Major Cause of Intracranial Bleeding in Fetal/Neonatal Alloimmune ThrombocytopeniaHLA-DRB3*01:01 is a predictor of immunization against human platelet antigen-1a but not of the severity of fetal and neonatal alloimmune thrombocytopenia.
P50
Q24294902-6A27EADA-2678-4A87-B635-2E2A78488CA3Q24673214-A8D328D8-133B-495A-B810-07B4F04447D5Q28268648-8E459D1A-A587-4E07-BAED-5B6B5A838A73Q28287935-8E421048-E1F6-48FD-A88A-1BE467550D45Q29012672-09E2699B-01A7-423E-A53A-46F7FFBFCF88Q31003895-AFEC8846-E54D-4ADD-8F25-9C8035ECE938Q33338014-2972BD3F-E179-413D-A646-6849D9CD5CE1Q33340927-BC0FA7C5-4156-46C2-8F5F-49F3EEEEBEC3Q33347825-524B4B1E-679E-414D-9C03-F50DB1736783Q33356942-602F19BA-CA1C-4AD8-B858-E81E17AEA720Q33361483-A4A30E3C-8D55-4D27-83AE-B117AFB7943AQ33365271-19D375CC-51D2-4BB0-850A-87D3A80453C6Q33365275-0C3F58B8-BFBE-4E30-8B14-9CE6F6B60699Q33369921-23D69A0F-73C7-4777-938A-E1760BB4E224Q33371168-F7F99640-1221-4FF6-88D5-E8045530EAA0Q33373781-696710FA-3647-4C0F-B51F-4A3CB837616AQ33375999-9FE7EF92-DD3C-40CD-8AB3-47BEFBCB43D2Q33377708-1196830D-B4E6-4244-B0EF-2D00ED8FF273Q33381967-8778D1A7-36DE-4FCC-A542-14277F4650ADQ33382966-C0A9708F-2C63-40D0-8B3F-2C1D811DAEC3Q33384867-0B5C1518-F94E-402D-9A14-04455D7C0535Q33387600-D1CC5831-5BDF-4C0C-8CCE-7B4CC098A2F3Q33393645-91500AFA-691A-469F-908F-6D8CAD1B604BQ33394218-4845D209-9E13-4772-AB7C-AE4621223484Q33395277-9FE0DFCB-6B08-4D6B-AEC7-33700DE0464DQ33397515-EE26F2D5-7686-4A56-8F99-7F5590DF1AA1Q33397553-F882FF29-B48E-4191-841D-48956B32D290Q33398430-4E64C78D-4C8E-4C87-AF3E-E5731586E24EQ33405050-E0C54611-1574-44D7-888E-D76712602176Q33407495-249D2531-5334-428F-B31F-4B0EB3924214Q33409929-2A11C716-6ACB-49D7-ADB4-183DDD36E8C6Q33410561-DFAFA6DF-2D3B-4167-BEE1-CD1DF99D8685Q33411070-9D542058-6954-459D-B4B4-2B6D6744ACB5Q33421975-07E64722-4136-4E6F-8EC5-72F44606F014Q33426085-4201CEF6-1C3C-48DD-AE7B-DDA0EE7B96F4Q33427385-5E19F7B3-F02B-4ABD-A404-C00B3D8C3F29Q33431639-8EB71DE4-D90E-4AAE-903A-34558C5EF43EQ33432275-5D4EBE14-5B7C-4CB3-B119-32317AFC5BF5Q33432924-2DCE99AB-CFF8-419D-999B-26C7A2543BDCQ33437901-A6CF6E6F-4C9C-4D1E-AE02-3E63B630FD77
P50
name
Sentot Santoso
@ast
Sentot Santoso
@en
Sentot Santoso
@nl
type
label
Sentot Santoso
@ast
Sentot Santoso
@en
Sentot Santoso
@nl
prefLabel
Sentot Santoso
@ast
Sentot Santoso
@en
Sentot Santoso
@nl